BE2010C024I2 - Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same - Google Patents

Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same

Info

Publication number: BE2010C024I2
Authority: BE; Belgium
Prior art keywords: isobutyloxyphenyl; cyano; methyl; producing; thiazolecarboxylic acid
Prior art date: 1998-06-19

Application number

BE2010C024C

Other languages

English (en)

Original Assignee

Teijin Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-19

Filing date

2010-05-12

Publication date

2018-08-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15953825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2010C024(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-05-12 Application filed by Teijin Ltd filed Critical Teijin Ltd

2018-08-24 Publication of BE2010C024I2 publication Critical patent/BE2010C024I2/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Thiazole And Isothizaole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BE2010C024C 1998-06-19 2010-05-12 Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same BE2010C024I2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP17307998		1998-06-19
PCT/JP1999/003258 WO1999065885A1 (fr)	1998-06-19	1999-06-18	Modifications polymorphes de 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-acide carboxylique et procedes de preparation associes
EP99957054A EP1020454B2 (fr)	1998-06-19	1999-06-18	Modifications polymorphes de 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-acide carboxylique et procedes de preparation associes

Publications (1)

Publication Number	Publication Date
BE2010C024I2 true BE2010C024I2 (en)	2018-08-24

Family

ID=15953825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2010C024C BE2010C024I2 (en)	1998-06-19	2010-05-12	Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same

Country Status (39)

Country	Link
US (1)	US6225474B1 (fr)
EP (4)	EP1020454B2 (fr)
JP (1)	JP3547707B2 (fr)
KR (1)	KR100511183B1 (fr)
CN (3)	CN1275126A (fr)
AT (2)	ATE522512T2 (fr)
AU (1)	AU748026B2 (fr)
BE (1)	BE2010C024I2 (fr)
BG (1)	BG64734B1 (fr)
BR (1)	BR9906539A (fr)
CA (2)	CA2566652C (fr)
CY (3)	CY1109720T1 (fr)
CZ (1)	CZ298170B6 (fr)
DE (2)	DE69941672D1 (fr)
DK (3)	DK1956015T4 (fr)
ES (3)	ES2336287T5 (fr)
FR (1)	FR10C0022I2 (fr)
GT (1)	GT199900216A (fr)
HK (2)	HK1029788A1 (fr)
HR (2)	HRP20000092C1 (fr)
HU (2)	HU230799B1 (fr)
ID (1)	ID25775A (fr)
IL (1)	IL134594A (fr)
IN (1)	IN191537B (fr)
IS (4)	IS9020A (fr)
LT (1)	LT1956014T (fr)
LU (1)	LU91682I2 (fr)
NO (1)	NO321308B1 (fr)
NZ (1)	NZ503326A (fr)
PL (1)	PL200710B1 (fr)
PT (3)	PT1956014T (fr)
RU (1)	RU2198169C3 (fr)
SI (3)	SI1956015T2 (fr)
SK (2)	SK287928B6 (fr)
TR (1)	TR200000458T1 (fr)
TW (1)	TWI248439B (fr)
UA (1)	UA57611C2 (fr)
WO (1)	WO1999065885A1 (fr)
ZA (1)	ZA200000737B (fr)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69941672D1 (de)	1998-06-19	2010-01-07	Teijin Ltd	Polymorphe modifikationen der 2-(3-cyano-4-isobutylphenyl)-4-methyl-5-thiazol-carbonsäure und verfahren zu ihrer herstellung
BR0211061A (pt) *	2001-07-10	2004-07-20	Upjohn Co	Cristais de tiazina oxazolidinonas e processos para isolar tais cristais
CN100364991C (zh)	2001-08-15	2008-01-30	法玛西雅厄普约翰美国公司	2,4-二甲基-1h-吡咯-3-甲酰胺衍生物的苹果酸盐的晶体、其制备方法和其组合物
AU2003223158B2 (en) *	2002-01-09	2008-01-17	Emisphere Technologies, Inc.	Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
JP2003261548A (ja) *	2002-03-07	2003-09-19	Teijin Ltd	２−（３−シアノ−４−イソブチルオキシフェニル）−４−メチル−５−チアゾールカルボン酸の結晶多形体の製造方法
US7361676B2 (en) *	2002-03-28	2008-04-22	Teijin Limited	Solid preparation containing single crystal form
CA2607953A1 (fr) *	2005-05-09	2006-11-16	Tap Pharmaceutical Products, Inc.	Methodes de traitement de la nephrolithiase
CN100430055C (zh) *	2005-11-11	2008-11-05	天津泰普药品科技发展有限公司	2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸和聚乙烯吡咯烷酮玻璃态固溶体及其制备方法
US8148542B2 (en)	2006-06-23	2012-04-03	Teijin Pharma Limited	Method for producing crystal polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid
CN101139325B (zh) *	2006-09-07	2010-05-12	上海医药工业研究院	2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法
CN101812035B (zh) *	2006-09-07	2012-03-21	上海医药工业研究院	2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法
US20080269226A1 (en) *	2006-11-13	2008-10-30	Christopher Lademacher	Methods for Preserving Renal Function Using Xanthine Oxidoreductase Inhibitors
US20090124623A1 (en) *	2006-11-13	2009-05-14	Christopher Lademacher	Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
CN102093309B (zh) *	2006-12-07	2012-07-04	重庆医药工业研究院有限责任公司	非布司他的晶型及其制备方法
CN102093308B (zh) *	2006-12-07	2012-08-29	重庆医药工业研究院有限责任公司	非布司他的晶型及其制备方法
CN1970547B (zh) *	2006-12-07	2011-04-06	重庆医药工业研究院有限责任公司	非布司他的晶型及其制备方法
BRPI0806608A2 (pt) *	2007-01-19	2011-09-06	Takeda Pharmaceuticals North America Inc	métodos para prevenir ou reduzir o número de surtos agudos de gota utilizando inibidores xantina oxidoredutase e agentes anti-inflamatórios
CN101412700B (zh) *	2007-10-19	2011-06-08	上海医药工业研究院	非布司他的晶型及其制备方法
CN101386605B (zh) *	2008-10-23	2010-09-08	中国科学院上海药物研究所	非布司他新型晶体及其制备方法
CN101759656B (zh) *	2008-12-12	2013-04-03	重庆医药工业研究院有限责任公司	非布司他新晶型及其制备方法
CN101768150B (zh) *	2009-01-05	2014-08-06	常州市第四制药厂有限公司	2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法
US20100311756A1 (en) *	2009-01-22	2010-12-09	Takeda Pharmaceuticals North America, Inc.	Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
CN101891702B (zh) *	2009-05-22	2012-07-04	重庆圣华曦药业股份有限公司	非布司他的晶体、制备方法及在药物中的应用
US8415481B2 (en) *	2009-06-10	2013-04-09	Teva Pharmaceuticals Usa, Inc.	Crystalline form of febuxostat
JP5519201B2 (ja) *	2009-07-15	2014-06-11	光孝北村	２−（３−シアノ−４−イソブチルオキシフェニル）−４−メチル−５−チアゾールカルボン酸の結晶多形体の製造方法
TWI516480B (zh) *	2009-07-15	2016-01-11	Teijin Pharma Ltd	A method for producing a crystalline polymorph of 2- (3-cyano-4-isobutyloxyphenyl) -4-methyl-5-thiazolecarboxylic acid by a poor solvent addition method
CN103936689B (zh) *	2009-07-17	2016-08-17	北京利乐生制药科技有限公司	2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法
WO2011080651A2 (fr)	2009-12-31	2011-07-07	Ranbaxy Laboratories Limited	Formes polymorphes de fébuxostat
US20130190366A1 (en)	2010-02-19	2013-07-25	Cadila Healthcare Limited	Substantially pure salts of febuxostat and processes for preparation thereof
EP2542540A1 (fr)	2010-03-04	2013-01-09	Ranbaxy Laboratories Limited	Polymorphe d'acide 2-[3-cyano-4-(2-méthylpropoxy) phényl]-4-méthylthiazole-5-carboxylique
WO2011134101A1 (fr) *	2010-04-27	2011-11-03	上海凯米侬医药科技有限公司	Nouvelle forme cristalline n du fébuxostat et sa méthode de préparation
CN101824005B (zh) *	2010-04-27	2012-06-27	上海凯米侬医药科技有限公司	一种非布索坦的晶型q及其制备方法
EP2563768A4 (fr) *	2010-04-29	2013-07-31	Reddys Lab Ltd Dr	Préparation of fébuxostat
IT1400310B1 (it)	2010-05-10	2013-05-24	Menarini Int Operations Lu Sa	Associazione di inibitori della xantina ossidasi e statine e loro uso.
IT1400609B1 (it)	2010-05-10	2013-06-14	Menarini Int Operations Lu Sa	Associazione di inibitori della xantina ossidasi e metformina e loro uso.
IT1400309B1 (it)	2010-05-10	2013-05-24	Menarini Int Operations Lu Sa	Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
IT1400311B1 (it)	2010-05-10	2013-05-24	Menarini Int Operations Lu Sa	Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
PL2399911T3 (pl)	2010-06-25	2016-01-29	Sandoz Ag	Polimorfy febuksostatu
TW201217347A (en)	2010-07-13	2012-05-01	Interquim Sa	Process for preparing the crystalline form a of febuxostat
WO2012020272A2 (fr)	2010-08-13	2012-02-16	EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársaság	Nouveaux sels, polymorphes et solvates d'un ingrédient pharmaceutiquement actif
CN103298466B (zh)	2010-09-10	2015-11-25	武田制药美国有限公司	茶碱和非布索坦的联合治疗方法
EP2619191A4 (fr) *	2010-09-24	2014-03-26	Hetero Research Foundation	Nouveaux polymorphes de febuxostat
CN102442971B (zh) *	2010-10-13	2014-06-18	欣凯医药化工中间体（上海）有限公司	非布司他的晶型及其制备方法
WO2012048861A1 (fr)	2010-10-14	2012-04-19	Gador S.A.	Nouvelle forme cristalline du febuxostat et son procédé de préparation
EP2632270A1 (fr) *	2010-10-28	2013-09-04	Mapi Pharma Limited	Polymorphes de febuxostat
TWI520732B (zh) *	2011-01-18	2016-02-11	輝瑞有限公司	固體分子分散液
CN102127033A (zh) *	2011-01-21	2011-07-20	北京虹湾医药技术有限公司	非布索坦晶型及其工业化制备方法
EP2502920A1 (fr)	2011-03-25	2012-09-26	Sandoz Ag	Procédé de cristallisation pour Febuxostat form A
WO2012131590A1 (fr)	2011-03-31	2012-10-04	Sandoz Ag	Procédé de préparation amélioré du fébuxostat et de sa forme cristalline polymorphe c
US20150031732A1 (en)	2011-04-15	2015-01-29	Ranbaxy Laboratories Limited	Febuxostat solid dispersion
WO2012153313A1 (fr)	2011-05-11	2012-11-15	Ranbaxy Laboratories Limited	Composition pharmaceutique de fébuxostat
WO2012168948A2 (fr) *	2011-06-06	2012-12-13	Hetero Research Foundation	Procédé de préparation de fébuxostat
WO2012172461A1 (fr)	2011-06-13	2012-12-20	Ranbaxy Laboratories Limited	Compositions pharmaceutiques de febuxostat
CN104114545B (zh)	2011-11-15	2018-06-01	迈兰实验室有限公司	用于制备非布索坦多晶型物的方法
WO2013088449A1 (fr) *	2011-12-16	2013-06-20	Natco Pharma Limited	Forme cristalline stable de febuxostat et procédé de préparation correspondant
EP2925306A1 (fr)	2012-07-12	2015-10-07	Alembic Pharmaceuticals Limited	Composition pharmaceutique de fébuxostat
EP2692342A1 (fr)	2012-07-30	2014-02-05	Interquim, S.A.	Procédé pour la préparation de compositions pharmaceutiques comprenant du Febuxostat sous la forme de comprimés
WO2014057461A1 (fr)	2012-10-11	2014-04-17	Ranbaxy Laboratories Limited	Procédé pour la préparation de forme cristalline g de fébuxostat
CN103936688A (zh) *	2013-01-21	2014-07-23	上海华拓医药科技发展股份有限公司	2-(3-氰基-4-(2-甲基丙氧基)苯基)-4-甲基-5-噻唑甲酸a晶的制备方法
DK2980085T3 (en) *	2013-03-29	2018-05-22	Teijin Pharma Ltd	pyrazole
CN103396378B (zh) *	2013-07-29	2015-06-10	杭州朱养心药业有限公司	非布司他结晶
CN103588724B (zh) *	2013-09-10	2015-05-20	杭州华东医药集团新药研究院有限公司	一种非布司他晶型a及其制备方法
RU2016119523A (ru) *	2013-10-22	2017-11-28	Ниппон Кемифар Ко., Лтд.	Мелкие кристаллы 2-[3-циано-4-(2-метилпропокси)фенил]-4-метилтиазол-5-карбоновой кислоты, продукт их тонкого измельчения и содержащие их твердые препараты
EP2881116A1 (fr)	2013-12-05	2015-06-10	Ranbaxy Laboratories Limited	Composition de febuxostat
EP2902016A1 (fr)	2014-01-30	2015-08-05	Alfred E. Tiefenbacher (GmbH & Co. KG)	Comprimé Febuxostat
CN103739568B (zh) *	2014-02-07	2015-09-16	浙江普洛康裕制药有限公司	2-(3-氰基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸a晶型的制备方法
CA2956553C (fr)	2014-07-30	2023-03-21	Teijin Pharma Limited	Derive de 1h-1,2,3,4-tetrazole benzene, formes cristallines connexes et utilisation comme inhibiteur de xanthine oxydase
EP3002006A1 (fr)	2014-10-01	2016-04-06	Bluepharma - Industria Farmacêutica, S.A.	Composition pharmaceutique capable de l'incorporation de febuxostat dans les modifications cristallines F10, II, G et A
CZ27857U1 (cs)	2014-12-12	2015-02-23	Zentiva, K.S.	Formulace obsahující tuhý roztok febuxostatu
JP2016150917A (ja) *	2015-02-17	2016-08-22	株式会社トクヤマ	バルサルタンの結晶の製造方法
WO2016171254A1 (fr) *	2015-04-22	2016-10-27	日本ケミファ株式会社	Cristaux d'acide 2-[3-cyano-4-(2-méthylpropoxy)phényl]-4-méthylthiazole-5-carboxylique, procédé de fabrication de ceux-ci, et utilisation de ceux-ci
EP3153158A1 (fr)	2015-10-09	2017-04-12	Stada Arzneimittel Ag	Pastille orale de febuxostat
CN107540630A (zh) *	2016-06-29	2018-01-05	康普药业股份有限公司	一种非布司他化合物及制备方法
GR1009119B (el)	2016-06-30	2017-09-18	"Φαρματεν Α.Β.Ε.Ε."	Φαρμακευτικο σκευασμα περιεχον ενα μη πουρινικο επιλεκτικο αναστολεα της οξειδασης της ξανθινης και μεθοδος παρασκευης αυτου
KR20180013563A (ko) *	2016-07-29	2018-02-07	한미정밀화학주식회사	고순도 결정형 페북소스타트의 개선된 제조 방법
CN106565627B (zh) *	2016-10-10	2020-01-10	扬子江药业集团有限公司	一种非布司他药用晶型的制备方法
GR1009659B (el)	2018-09-07	2019-11-28	Φαρματεν Α.Β.Ε.Ε.	Φαρμακευτικο σκευασμα που περιλαμβανει ενα συμπλοκο αλατος της φεβουξοστατης με οξειδιο του μαγνησιου και μεθοδος για την παρασκευη αυτου
CN113166017B (zh) *	2018-09-28	2024-03-29	株式会社钟化	稳定性优异的还原型辅酶q10结晶的制造方法
CN112390766B (zh) *	2019-08-13	2022-09-06	浙江天宇药业股份有限公司	一种非布司他a晶型的制备方法
CN111004191A (zh) *	2019-10-24	2020-04-14	武汉光谷亚太医药研究院有限公司	一种大粒径非布司他a晶的制备方法
JP7506475B2 (ja) *	2019-12-26	2024-06-26	東和薬品株式会社	フェブキソスタット製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8506572D0 (en) †	1985-03-14	1985-04-17	Appointrose Ltd	Fire-resistant enclosures
EP0237608B1 (fr)	1986-03-21	1992-01-29	HEUMANN PHARMA GMBH & CO	La forme sigma cristalline, anhydre de 2-[4-(2-furoyl-(2-pipérazin)-1-yl]-4-amino-6,7-diméthoxyquinazoline hydrochlorure et procédé pour sa préparation
US5015646A (en)	1987-08-28	1991-05-14	Bristol-Myers Squibb Co.	Pharmaceutically useful polymorphic modification of buspirone
KR100221041B1 (ko) *	1990-11-30	1999-09-15	야스이 쇼사꾸	2-아릴티아졸 유도체 및 그의 약제학적 조성물
JP2706037B2 (ja) *	1993-04-13	1998-01-28	帝人株式会社	シアノ化合物およびその製造方法
JP3202607B2 (ja) *	1996-08-01	2001-08-27	帝人株式会社	２−（４−アルコキシ−３−シアノフェニル）チアゾール誘導体の製造法
DE69941672D1 (de)	1998-06-19	2010-01-07	Teijin Ltd	Polymorphe modifikationen der 2-(3-cyano-4-isobutylphenyl)-4-methyl-5-thiazol-carbonsäure und verfahren zu ihrer herstellung
US7361676B2 (en)	2002-03-28	2008-04-22	Teijin Limited	Solid preparation containing single crystal form

1999
- 1999-06-18 DE DE69941672T patent/DE69941672D1/de not_active Expired - Lifetime
- 1999-06-18 SI SI9931060T patent/SI1956015T2/sl unknown
- 1999-06-18 CN CN99801366A patent/CN1275126A/zh active Pending
- 1999-06-18 PT PT80059330T patent/PT1956014T/pt unknown
- 1999-06-18 SK SK220-2000A patent/SK287928B6/sk not_active IP Right Cessation
- 1999-06-18 DE DE122010000013C patent/DE122010000013I1/de active Pending
- 1999-06-18 CN CN201010562692.0A patent/CN102020617B/zh not_active Expired - Lifetime
- 1999-06-18 UA UA2000031530A patent/UA57611C2/uk unknown
- 1999-06-18 IS IS9020A patent/IS9020A/is unknown
- 1999-06-18 EP EP99957054A patent/EP1020454B2/fr not_active Expired - Lifetime
- 1999-06-18 TR TR2000/00458T patent/TR200000458T1/xx unknown
- 1999-06-18 SK SK5040-2010A patent/SK287946B6/sk not_active IP Right Cessation
- 1999-06-18 KR KR10-2000-7001678A patent/KR100511183B1/ko active Protection Beyond IP Right Term
- 1999-06-18 NZ NZ503326A patent/NZ503326A/en not_active IP Right Cessation
- 1999-06-18 PT PT99957054T patent/PT1020454E/pt unknown
- 1999-06-18 CZ CZ20000582A patent/CZ298170B6/cs not_active IP Right Cessation
- 1999-06-18 CA CA002566652A patent/CA2566652C/fr not_active Expired - Lifetime
- 1999-06-18 HU HU1300546A patent/HU230799B1/hu unknown
- 1999-06-18 BR BR9906539-8A patent/BR9906539A/pt not_active Application Discontinuation
- 1999-06-18 AT AT08005934T patent/ATE522512T2/de active
- 1999-06-18 HU HU0004325A patent/HU229405B1/hu active Protection Beyond IP Right Term
- 1999-06-18 DK DK08005934.8T patent/DK1956015T4/en active
- 1999-06-18 US US09/485,861 patent/US6225474B1/en not_active Expired - Lifetime
- 1999-06-18 ES ES99957054T patent/ES2336287T5/es not_active Expired - Lifetime
- 1999-06-18 PT PT08005934T patent/PT1956015E/pt unknown
- 1999-06-18 LT LTEP08005933.0T patent/LT1956014T/lt unknown
- 1999-06-18 EP EP10185673.0A patent/EP2404910A3/fr not_active Withdrawn
- 1999-06-18 SI SI9931085T patent/SI1956014T1/sl unknown
- 1999-06-18 AT AT99957054T patent/ATE449765T1/de active
- 1999-06-18 JP JP2000554711A patent/JP3547707B2/ja not_active Expired - Fee Related
- 1999-06-18 CN CN2012101505038A patent/CN102659712A/zh active Pending
- 1999-06-18 SI SI9931037T patent/SI1020454T2/sl unknown
- 1999-06-18 ES ES08005933T patent/ES2718467T3/es not_active Expired - Lifetime
- 1999-06-18 ES ES08005934T patent/ES2371786T5/es not_active Expired - Lifetime
- 1999-06-18 IL IL13459499A patent/IL134594A/en not_active IP Right Cessation
- 1999-06-18 DK DK99957054.2T patent/DK1020454T4/da active
- 1999-06-18 CA CA002301863A patent/CA2301863C/fr not_active Expired - Lifetime
- 1999-06-18 RU RU2000107108A patent/RU2198169C3/ru active
- 1999-06-18 WO PCT/JP1999/003258 patent/WO1999065885A1/fr active Application Filing
- 1999-06-18 PL PL338780A patent/PL200710B1/pl unknown
- 1999-06-18 EP EP08005934.8A patent/EP1956015B2/fr not_active Expired - Lifetime
- 1999-06-18 AU AU42892/99A patent/AU748026B2/en not_active Expired
- 1999-06-18 DK DK08005933.0T patent/DK1956014T3/en active
- 1999-06-18 EP EP08005933.0A patent/EP1956014B1/fr not_active Revoked
- 1999-06-18 ID IDW20000302D patent/ID25775A/id unknown
- 1999-12-16 GT GT199900216A patent/GT199900216A/es unknown
- 1999-12-16 TW TW088122172A patent/TWI248439B/zh not_active IP Right Cessation
2000
- 2000-02-15 ZA ZA200000737A patent/ZA200000737B/xx unknown
- 2000-02-16 BG BG104159A patent/BG64734B1/bg unknown
- 2000-02-16 IN IN9MU2000 patent/IN191537B/en unknown
- 2000-02-17 NO NO20000789A patent/NO321308B1/no not_active IP Right Cessation
- 2000-02-17 IS IS5377A patent/IS2886B/is unknown
- 2000-02-18 HR HR20000092A patent/HRP20000092C1/xx not_active IP Right Cessation
2001
- 2001-01-08 HK HK01100199.8A patent/HK1029788A1/xx not_active IP Right Cessation
2008
- 2008-11-12 HK HK08112377.0A patent/HK1118293A1/xx not_active IP Right Cessation
2010
- 2010-01-05 CY CY20101100014T patent/CY1109720T1/el unknown
- 2010-03-30 CY CY2010006C patent/CY2010006I2/el unknown
- 2010-04-12 FR FR10C0022C patent/FR10C0022I2/fr active Active
- 2010-04-22 LU LU91682C patent/LU91682I2/fr unknown
- 2010-05-12 BE BE2010C024C patent/BE2010C024I2/fr unknown
2011
- 2011-09-16 CY CY20111100901T patent/CY1111841T1/el unknown
2012
- 2012-03-07 HR HRP20120217AA patent/HRP20120217B1/hr not_active IP Right Cessation
2013
- 2013-01-25 IS IS9021A patent/IS3002B/is unknown
- 2013-01-25 IS IS9022A patent/IS9022A/is unknown

Also Published As

Publication number	Publication date
SI1956015T2 (sl)	2018-12-31
BG104159A (en)	2000-08-31
ES2336287T5 (es)	2013-04-02
IN191537B (fr)	2003-12-06
DK1956015T4 (en)	2019-02-11
SI1956014T1 (sl)	2019-02-28
US6225474B1 (en)	2001-05-01
ATE522512T2 (de)	2011-09-15
CZ298170B6 (cs)	2007-07-11
IL134594A0 (en)	2001-04-30
EP1020454B2 (fr)	2013-01-23
AU748026B2 (en)	2002-05-30
EP2404910A3 (fr)	2014-10-29
IS5377A (is)	2000-02-17
DK1020454T3 (da)	2010-01-04
HK1118293A1 (fr)	2009-02-06
DK1956014T3 (en)	2019-04-15
CZ2000582A3 (cs)	2000-07-12
ES2371786T5 (es)	2019-04-22
BG64734B1 (bg)	2006-01-31
ID25775A (id)	2000-11-02
HRPK20000092B1 (en)	2001-10-31
HU230799B1 (hu)	2018-06-28
ES2718467T3 (es)	2019-07-02
CA2566652C (fr)	2008-10-21
BR9906539A (pt)	2000-08-15
PT1020454E (pt)	2009-12-21
TWI248439B (en)	2006-02-01
KR20010023061A (ko)	2001-03-26
DK1956015T3 (da)	2011-09-26
SI1956015T1 (sl)	2011-10-28
UA57611C2 (uk)	2003-06-16
EP1956015B2 (fr)	2018-11-14
IS3002B (is)	2018-09-15
SI1020454T2 (sl)	2013-03-29
EP1956014A3 (fr)	2008-08-20
CN1275126A (zh)	2000-11-29
FR10C0022I1 (fr)	2010-05-14
GT199900216A (es)	2001-06-08
EP1956014A2 (fr)	2008-08-13
SK287928B6 (sk)	2012-04-03
SI1020454T1 (sl)	2010-02-26
HRP20000092C1 (en)	2012-04-30
NO321308B1 (no)	2006-04-24
HRP20000092A2 (en)	2000-08-31
LU91682I2 (fr)	2010-06-22
LT1956014T (lt)	2019-03-25
EP1956015B1 (fr)	2011-08-31
PT1956015E (pt)	2011-11-02
WO1999065885A1 (fr)	1999-12-23
NO20000789L (no)	2000-02-17
CA2566652A1 (fr)	1999-12-23
CY2010006I1 (el)	2012-01-25
IS9021A (is)	2013-01-25
CN102020617B (zh)	2019-04-23
TR200000458T1 (tr)	2000-10-23
IS9022A (is)	2013-01-25
HUP0004325A3 (en)	2001-12-28
CA2301863A1 (fr)	1999-12-23
RU2198169C3 (ru)	2017-07-20
PT1956014T (pt)	2019-04-24
EP1020454A4 (fr)	2002-05-15
JP3547707B2 (ja)	2004-07-28
PL200710B1 (pl)	2009-01-30
HRP20120217B1 (hr)	2019-04-05
CN102020617A (zh)	2011-04-20
EP1020454A1 (fr)	2000-07-19
DE69941672D1 (de)	2010-01-07
EP1956015A3 (fr)	2008-09-17
CA2301863C (fr)	2009-01-27
ATE449765T1 (de)	2009-12-15
DK1020454T4 (da)	2013-11-25
CY2010006I2 (el)	2012-01-25
IS2886B (is)	2014-07-15
HUP0004325A2 (hu)	2001-10-28
HK1029788A1 (en)	2001-04-12
KR100511183B1 (ko)	2005-08-30
PL338780A1 (en)	2000-11-20
SK287946B6 (sk)	2012-06-04
DE122010000013I1 (de)	2010-07-08
IS9020A (is)	2013-01-25
EP2404910A2 (fr)	2012-01-11
SK2202000A3 (en)	2000-11-07
ES2336287T3 (es)	2010-04-09
EP1956014B1 (fr)	2019-01-16
AU4289299A (en)	2000-01-05
EP1956015A2 (fr)	2008-08-13
NZ503326A (en)	2002-02-01
RU2198169C2 (ru)	2003-02-10
NO20000789D0 (no)	2000-02-17
IL134594A (en)	2004-12-15
ZA200000737B (en)	2000-09-08
HRP20120217A2 (hr)	2012-05-31
LU91682I9 (fr)	2019-01-09
EP1020454B1 (fr)	2009-11-25
CY1109720T1 (el)	2012-01-25
CN102659712A (zh)	2012-09-12
CY1111841T1 (el)	2015-10-07
FR10C0022I2 (fr)	2013-08-16
HU229405B1 (en)	2013-12-30
ES2371786T3 (es)	2012-01-10

Publication	Publication Date	Title
BE2010C024I2 (en)	2018-08-24	Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
WO2002057783A3 (fr)	2003-08-07	Methodes de criblage de ligands gpr40
MY115512A (en)	2003-06-30	Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
AU3517299A (en)	1999-09-27	Method for non-oxidative production of formaldehyde from methanol
ECSP993280A (es)	2001-07-27	Polimorfos de acido 2- (3- ciano -4 -isobutiloxi fenil) -4 -metil -5-tiazol carboxilico y metodo de produccion de los mismos
WO2000018777A3 (fr)	2001-01-04	Procede de synthese de c-glycosides d'acides ulosoniques
UY25863A1 (es)	2000-08-21	Polimorfos de acido 2-(3-ciano-4-isobutiloxi fenil)4-metil 5 - tiazol carboxilico y metodo de produccion de los mismos.